Sally Del Principe
Corporate Officer/Principal bij Lupton del Principe Associates Ltd.
Actieve functies van Sally Del Principe
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Lupton del Principe Associates Ltd. | Corporate Officer/Principal | 09-04-2010 | - |
Loopbaan van Sally Del Principe
Eerdere bekende functies van Sally Del Principe
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Financieel Directeur/CFO | 09-04-2010 | 28-10-2010 |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
| Lupton del Principe Associates Ltd. |
- Beurs
- Insiders
- Sally Del Principe
- Ervaring
